Pragmatic randomized trial of Risperdal Consta versus oral atypical antipsychotics in poorly aderant subjects with schizophrenia in a routine care setting. Protocol RISSCH4055; Phase IV (risperidone microspheres)

Trial Profile

Pragmatic randomized trial of Risperdal Consta versus oral atypical antipsychotics in poorly aderant subjects with schizophrenia in a routine care setting. Protocol RISSCH4055; Phase IV (risperidone microspheres)

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 12 Sep 2014

At a glance

  • Drugs Antipsychotics; Risperidone
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top